New cell therapy offers hope for leukemia patients too sick for chemo
NCT ID NCT07335094
First seen Jan 12, 2026 · Last updated May 02, 2026 · Updated 18 times
Summary
This early-stage study tests a new treatment using a patient's own immune cells, called CAR-T cells, that are specially designed to attack cancer. The study includes 60 adults aged 18-80 with newly diagnosed B-cell acute lymphoblastic leukemia or lymphoma who cannot handle strong chemotherapy. Participants receive one infusion of these cells and are followed for three years to see if the treatment is safe and helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.